HCAT - Health Catalyst, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $1.77 DETAILS

Stock News

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SALT LAKE CITY, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that on September 14, 2026, the Compensation Committee of the Company's Board of Directors granted 2,747,385 restricted stock units (the “RSUs”) to Simeon Kohl under the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan (the “Inducement Plan”) in connection with Mr. Kohl's previously announced appointment as Chief Executive Officer and President of the Company effective on September 14, 2026. The awards were granted as inducement material to Mr. Kohl's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Sep 14, 2026 02:32 PM • globenewswire.com

Health Catalyst Strengthens Its Board with the Appointment of Tami Reller

Reller Joins Health Catalyst as it Enters Its Next Phase of Growth SALT LAKE CITY, Sept. 14, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst", NASDAQ: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Tami Reller has been appointed to its board of directors (Board), effective October 1, 2026.

Sep 14, 2026 12:19 PM • prnewswire.com

Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company's Board of Directors, effective September 14, 2026.

Sep 08, 2026 04:00 AM • globenewswire.com

Hsbc Holdings PLC Invests $809,000 in Health Catalyst, Inc. $HCAT

Hsbc Holdings PLC bought a new stake in Health Catalyst, Inc. (NASDAQ: HCAT) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 408,634 shares of the company's stock, valued at approximately $809,000. Hsbc Holdings PLC owned approximately 0.54% of Health Catalyst

Sep 01, 2026 11:48 PM • defenseworld.net

Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026.

Aug 31, 2026 12:05 PM • globenewswire.com

Critical Survey: Aclarion (NASDAQ:ACONW) and Health Catalyst (NASDAQ:HCAT)

Health Catalyst (NASDAQ: HCAT - Get Free Report) and Aclarion (NASDAQ: ACONW - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations. Insider and Institutional Ownership 85.0% of Health Catalyst shares

Aug 23, 2026 11:59 PM • defenseworld.net

Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of “Hold” from Analysts

Health Catalyst, Inc. (NASDAQ: HCAT - Get Free Report) has earned an average rating of "Hold" from the thirteen analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and four have assigned a buy recommendation to the company. The

Aug 11, 2026 10:15 PM • defenseworld.net

Health Catalyst (NASDAQ:HCAT) and Lynx Global Digital Finance (OTCMKTS:CNONF) Head-To-Head Review

Health Catalyst (NASDAQ: HCAT - Get Free Report) and Lynx Global Digital Finance (OTCMKTS:CNONF - Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership. Earnings and Valuation This table compares

Aug 11, 2026 10:15 PM • defenseworld.net

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst NASDAQ: HCAT reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.

Aug 06, 2026 07:05 PM • marketbeat.com

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Aug 06, 2026 05:54 PM • seekingalpha.com

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aug 06, 2026 03:01 PM • zacks.com

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.04 per share a year ago.

Aug 06, 2026 02:41 PM • zacks.com

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Company retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance. SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026.

Aug 06, 2026 12:03 PM • prnewswire.com

Health Catalyst Reports Second Quarter 2026 Results

SALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026. “We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance," said Ben Albert, Chief Executive Officer of Health Catalyst.

Aug 06, 2026 12:03 PM • globenewswire.com

Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026

SALT LAKE CITY, July 28, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.

Jul 28, 2026 01:30 PM • globenewswire.com

Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails

Health Catalyst NASDAQ: HCAT stockholders approved three of four proposals presented at the company's 2026 annual meeting, including the election of two directors, ratification of the company's auditor and an advisory vote on executive compensation. A proposal to phase out the company's classified board structure did not receive the required level of support.

Jul 16, 2026 02:03 PM • marketbeat.com

Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “AI ROI in Healthcare: Real vs Hype Debate,” with Ben Albert, Chief Executive Officer, on Wednesday, June 24, 2026, at 3:30pm ET.

Jun 16, 2026 12:05 PM • globenewswire.com

Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield

PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ: HCAT).

Jun 04, 2026 06:06 AM • prnewswire.com

Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation

Health Catalyst today announced it has signed a definitive agreement to divest Vitalware, its mid-revenue cycle business, to Med-Metrix for $147 million.

Jun 04, 2026 05:03 AM • globenewswire.com